HK1054041A1 - Process for reacting alkaloids and use of the reaction products - Google Patents

Process for reacting alkaloids and use of the reaction products

Info

Publication number
HK1054041A1
HK1054041A1 HK03106188.6A HK03106188A HK1054041A1 HK 1054041 A1 HK1054041 A1 HK 1054041A1 HK 03106188 A HK03106188 A HK 03106188A HK 1054041 A1 HK1054041 A1 HK 1054041A1
Authority
HK
Hong Kong
Prior art keywords
reaction products
alkaloids
reacting
reacting alkaloids
products
Prior art date
Application number
HK03106188.6A
Other languages
English (en)
Inventor
Nowicky Wassyl
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Publication of HK1054041A1 publication Critical patent/HK1054041A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G5/00—Alkaloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/564—Three-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
    • C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK03106188.6A 2001-11-15 2003-08-29 Process for reacting alkaloids and use of the reaction products HK1054041A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH02094/01A CH695417A5 (de) 2001-11-15 2001-11-15 Verfahren zur Umsetzung von Alkaloiden.

Publications (1)

Publication Number Publication Date
HK1054041A1 true HK1054041A1 (en) 2003-11-14

Family

ID=4567486

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03106188.6A HK1054041A1 (en) 2001-11-15 2003-08-29 Process for reacting alkaloids and use of the reaction products

Country Status (39)

Country Link
US (1) US20050043340A1 (xx)
EP (1) EP1443943B1 (xx)
JP (1) JP2005509006A (xx)
KR (1) KR100849488B1 (xx)
CN (1) CN100436462C (xx)
AR (1) AR037527A1 (xx)
AT (1) ATE485826T1 (xx)
AU (1) AU2002346888B2 (xx)
BR (1) BR0214173A (xx)
CA (1) CA2465723C (xx)
CH (1) CH695417A5 (xx)
CO (1) CO5580784A2 (xx)
CR (1) CR7340A (xx)
CU (1) CU23451B7 (xx)
CY (1) CY1111139T1 (xx)
DE (1) DE60238134D1 (xx)
DK (1) DK1443943T3 (xx)
EA (1) EA007097B1 (xx)
EC (1) ECSP045107A (xx)
ES (1) ES2353207T3 (xx)
GE (1) GEP20053701B (xx)
HK (1) HK1054041A1 (xx)
HR (1) HRP20040430A2 (xx)
HU (1) HU229688B1 (xx)
IL (2) IL161766A0 (xx)
IS (1) IS2812B (xx)
MA (1) MA26232A1 (xx)
MX (1) MXPA04004643A (xx)
NO (1) NO334701B1 (xx)
NZ (1) NZ532941A (xx)
PL (1) PL212111B1 (xx)
PT (1) PT1443943E (xx)
RS (1) RS51219B (xx)
SA (1) SA02230496B1 (xx)
TN (1) TNSN04084A1 (xx)
TW (1) TWI262080B (xx)
UA (1) UA76535C2 (xx)
WO (1) WO2003041721A1 (xx)
ZA (1) ZA200403371B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1459753A1 (en) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
WO2006053680A1 (en) * 2004-11-19 2006-05-26 Nowicky Wassili Ex vivo cancer diagnostic method
WO2006053649A1 (en) * 2004-11-19 2006-05-26 Nowicky Wassili Method for the detection of cancer
WO2007073919A2 (en) 2005-12-28 2007-07-05 Nowicky Wassili Method and kit for the detection of cancer
ITMI20080284A1 (it) * 2008-02-22 2009-08-23 Indena Spa Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
CA2941315C (en) * 2016-08-12 2018-03-06 Api Labs Inc. High thebaine poppy and methods of producing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU368254A1 (ru) * 1969-06-16 1973-01-26 А. И. Потопальский , В. М. Новицкий Львовский государственный медицинский институт Способ получения соединений тиофосфамида с алкалоидами чистотела большого
US3865830A (en) * 1969-06-16 1975-02-11 Nikolai Mikhailovich Turkevich Thiophosphamide derivatives of isoquinoline alkaloids, method of producing and application thereof
AT354644B (de) * 1975-12-19 1980-01-25 Nowicky Wassili Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure
AT377988B (de) * 1976-06-28 1985-05-28 Nowicky Wassili Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
AT407608B (de) * 1994-03-18 2001-05-25 Nowicky Wassili Mittel zur behandlung von osteoporose
AT407833B (de) * 1995-06-01 2001-06-25 Nowicky Wassyl Dr Mittel zur behandlung von strahlenschäden
AT408719B (de) * 2000-03-22 2002-02-25 Nowicky Wassili Mittel zur behandlung von hepatitis c

Also Published As

Publication number Publication date
SA02230496B1 (ar) 2008-09-10
HU229688B1 (en) 2014-04-28
PT1443943E (pt) 2010-12-03
AU2002346888B2 (en) 2007-03-22
BR0214173A (pt) 2004-09-28
TNSN04084A1 (en) 2006-06-01
CA2465723A1 (en) 2003-05-22
HRP20040430B1 (xx) 2012-11-30
AU2002346888C1 (en) 2003-05-26
MA26232A1 (fr) 2004-07-01
AR037527A1 (es) 2004-11-17
PL368879A1 (en) 2005-04-04
IL161766A0 (en) 2005-11-20
EP1443943A1 (en) 2004-08-11
GEP20053701B (en) 2005-12-12
DK1443943T3 (da) 2011-02-14
CY1111139T1 (el) 2015-06-11
NO20041845D0 (no) 2004-05-05
IS2812B (is) 2012-11-15
MXPA04004643A (es) 2005-03-14
RS51219B (sr) 2010-12-31
NZ532941A (en) 2006-08-31
CR7340A (es) 2004-12-06
NO334701B1 (no) 2014-05-12
CN1422859A (zh) 2003-06-11
RS40804A (xx) 2006-12-15
WO2003041721A1 (en) 2003-05-22
CU23451B7 (es) 2009-10-16
US20050043340A1 (en) 2005-02-24
IS7245A (is) 2004-04-30
TWI262080B (en) 2006-09-21
ECSP045107A (es) 2004-06-28
HRP20040430A2 (en) 2004-08-31
ATE485826T1 (de) 2010-11-15
PL212111B1 (pl) 2012-08-31
ZA200403371B (en) 2005-05-04
HUP0402365A2 (hu) 2005-02-28
EA007097B1 (ru) 2006-06-30
EP1443943B1 (en) 2010-10-27
CA2465723C (en) 2010-01-05
CN100436462C (zh) 2008-11-26
JP2005509006A (ja) 2005-04-07
CO5580784A2 (es) 2005-11-30
DE60238134D1 (de) 2010-12-09
CH695417A5 (de) 2006-05-15
ES2353207T3 (es) 2011-02-28
UA76535C2 (en) 2006-08-15
KR20050040859A (ko) 2005-05-03
KR100849488B1 (ko) 2008-07-31
IL161766A (en) 2009-11-18
EA200400679A1 (ru) 2004-10-28
NO20041845L (no) 2004-06-25

Similar Documents

Publication Publication Date Title
EP1427743A4 (en) SYNTHESIS OF PYRAZOLOPYRIMIDINES
PT1644384E (pt) Processo e intermediários para a síntese de entecavir
AU2001273764A1 (en) Process for the preparation of substituted octanoyl amides
GB9927682D0 (en) Process for the manufacture of shaped articles
AU7376301A (en) Process for the preparation of substituted octanoyl amides
EG22992A (en) Process for the preparation of urea
ZA200307448B (en) Process and apparatus for the preparation of synthesis gas.
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
HUP0401600A3 (en) Process for the preparation of 14-hydroxymorphine derivatives
EG23247A (en) Process and plant for the heterogeneous synthesis of chemical compounds.
SI1423360T1 (sl) Postopek za izdelavo cilastatina
GB9905422D0 (en) Process for the production of olefins
SI1403264T1 (en) Process for the industrial synthesis of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxydimethylester
HK1054041A1 (en) Process for reacting alkaloids and use of the reaction products
AU2002219713A1 (en) Process and apparatus for the production of ammonia
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
IL162770A0 (en) Process for the preparation methylsteroids of 7
IL164788A0 (en) Process for the preparation of 3-isochromanone
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
IL149713A0 (en) Process for the production of trifluormethylacetophenones
AU2002228672A1 (en) Branched reaction products of amines and multifunctional compounds
GB0210651D0 (en) Catalytic process for the preparation of functionalised heterocyclic compounds and uses of such functionalised heterocyclic compounds
IL140300A0 (en) Process for the preparation of amides
GB0105878D0 (en) Novel process for the preparation of pyrazoloprimidinones
GB0115897D0 (en) Process for the preparation of chemical compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151115